Hubei Guangji Pharmaceutical Co., Ltd. (000952.SZ)
CNY 6.24
(-0.79%)
CNY 6.24
(-0.79%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.63 Billion CNY | 67.52% |
| 2022 | 977.24 Million CNY | 63.39% |
| 2021 | 598.09 Million CNY | -2.55% |
| 2020 | 613.74 Million CNY | -23.49% |
| 2019 | 802.2 Million CNY | -1.25% |
| 2018 | 812.32 Million CNY | -7.34% |
| 2017 | 876.64 Million CNY | -10.06% |
| 2016 | 974.7 Million CNY | -11.94% |
| 2015 | 1.1 Billion CNY | 2.77% |
| 2014 | 1.07 Billion CNY | 31.86% |
| 2013 | 816.78 Million CNY | 2.62% |
| 2012 | 795.92 Million CNY | 23.77% |
| 2011 | 643.06 Million CNY | 17.98% |
| 2010 | 545.06 Million CNY | 11.94% |
| 2009 | 486.93 Million CNY | 23.03% |
| 2008 | 395.78 Million CNY | 21.49% |
| 2007 | 325.76 Million CNY | 5.99% |
| 2006 | 307.34 Million CNY | -12.36% |
| 2005 | 350.68 Million CNY | -9.79% |
| 2004 | 388.76 Million CNY | 10.32% |
| 2003 | 352.38 Million CNY | 12.56% |
| 2002 | 313.04 Million CNY | 13.85% |
| 2001 | 274.96 Million CNY | 41.24% |
| 2000 | 194.67 Million CNY | -2.41% |
| 1999 | 199.48 Million CNY | 6.79% |
| 1998 | 186.8 Million CNY | 11.96% |
| 1997 | 166.84 Million CNY | 50.69% |
| 1996 | 110.71 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 1.67 Billion CNY | 2.3% |
| 2024 Q2 | 1.84 Billion CNY | 10.11% |
| 2024 Q3 | 1.89 Billion CNY | 2.63% |
| 2023 Q2 | 1.77 Billion CNY | 75.81% |
| 2023 Q3 | 1.69 Billion CNY | -4.47% |
| 2023 Q1 | 1 Billion CNY | 3.27% |
| 2023 FY | 1.63 Billion CNY | 67.52% |
| 2023 Q4 | 1.63 Billion CNY | -3.42% |
| 2022 FY | 977.24 Million CNY | 63.39% |
| 2022 Q4 | 977.24 Million CNY | 9.42% |
| 2022 Q3 | 893.13 Million CNY | 18.79% |
| 2022 Q2 | 751.87 Million CNY | -12.38% |
| 2022 Q1 | 858.07 Million CNY | 43.47% |
| 2021 Q3 | 613.38 Million CNY | -20.06% |
| 2021 Q4 | 598.09 Million CNY | -2.49% |
| 2021 Q1 | 572.01 Million CNY | -6.8% |
| 2021 Q2 | 767.27 Million CNY | 34.13% |
| 2021 FY | 598.09 Million CNY | -2.55% |
| 2020 Q2 | 749.25 Million CNY | -4.47% |
| 2020 Q1 | 784.33 Million CNY | -2.23% |
| 2020 Q3 | 710.27 Million CNY | -5.2% |
| 2020 Q4 | 613.74 Million CNY | -13.59% |
| 2020 FY | 613.74 Million CNY | -23.49% |
| 2019 Q2 | 882.49 Million CNY | -0.23% |
| 2019 Q1 | 884.5 Million CNY | 8.89% |
| 2019 FY | 802.2 Million CNY | -1.25% |
| 2019 Q3 | 790.92 Million CNY | -10.38% |
| 2019 Q4 | 802.2 Million CNY | 1.43% |
| 2018 Q1 | 858.82 Million CNY | -2.03% |
| 2018 FY | 812.32 Million CNY | -7.34% |
| 2018 Q4 | 812.32 Million CNY | 9.36% |
| 2018 Q3 | 742.82 Million CNY | -10.12% |
| 2018 Q2 | 826.43 Million CNY | -3.77% |
| 2017 Q2 | 903.21 Million CNY | 0.67% |
| 2017 FY | 876.64 Million CNY | -10.06% |
| 2017 Q1 | 897.19 Million CNY | -7.95% |
| 2017 Q3 | 955.96 Million CNY | 5.84% |
| 2017 Q4 | 876.64 Million CNY | -8.3% |
| 2016 Q2 | 1.08 Billion CNY | -2.31% |
| 2016 FY | 974.7 Million CNY | -11.94% |
| 2016 Q4 | 974.7 Million CNY | -1.81% |
| 2016 Q3 | 992.66 Million CNY | -8.66% |
| 2016 Q1 | 1.11 Billion CNY | 0.51% |
| 2015 Q2 | 1.22 Billion CNY | 21.99% |
| 2015 FY | 1.1 Billion CNY | 2.77% |
| 2015 Q4 | 1.1 Billion CNY | 0.11% |
| 2015 Q3 | 1.1 Billion CNY | -9.99% |
| 2015 Q1 | 1 Billion CNY | -6.5% |
| 2014 Q2 | 877.74 Million CNY | 5.78% |
| 2014 Q4 | 1.07 Billion CNY | 22.95% |
| 2014 FY | 1.07 Billion CNY | 31.86% |
| 2014 Q1 | 829.76 Million CNY | 1.59% |
| 2014 Q3 | 875.97 Million CNY | -0.2% |
| 2013 FY | 816.78 Million CNY | 2.62% |
| 2013 Q3 | 860.73 Million CNY | 4.11% |
| 2013 Q2 | 826.78 Million CNY | -3.1% |
| 2013 Q1 | 853.24 Million CNY | 7.2% |
| 2013 Q4 | 816.78 Million CNY | -5.11% |
| 2012 Q4 | 795.92 Million CNY | 8.96% |
| 2012 Q3 | 730.44 Million CNY | 11.33% |
| 2012 Q1 | 688.76 Million CNY | 7.11% |
| 2012 FY | 795.92 Million CNY | 23.77% |
| 2012 Q2 | 656.11 Million CNY | -4.74% |
| 2011 FY | 643.06 Million CNY | 17.98% |
| 2011 Q2 | 598.82 Million CNY | -0.62% |
| 2011 Q4 | 643.06 Million CNY | 1.72% |
| 2011 Q1 | 602.54 Million CNY | 10.55% |
| 2011 Q3 | 632.19 Million CNY | 5.57% |
| 2010 Q2 | 583.25 Million CNY | 24.18% |
| 2010 FY | 545.06 Million CNY | 11.94% |
| 2010 Q3 | 578 Million CNY | -0.9% |
| 2010 Q1 | 469.68 Million CNY | -3.54% |
| 2010 Q4 | 545.06 Million CNY | -5.7% |
| 2009 Q4 | 486.93 Million CNY | -4.31% |
| 2009 Q1 | 424.52 Million CNY | 7.26% |
| 2009 Q2 | 538.91 Million CNY | 26.95% |
| 2009 Q3 | 508.87 Million CNY | -5.58% |
| 2009 FY | 486.93 Million CNY | 23.03% |
| 2008 Q3 | 323.27 Million CNY | -0.87% |
| 2008 Q4 | 395.78 Million CNY | 22.43% |
| 2008 Q1 | 321.74 Million CNY | -1.23% |
| 2008 FY | 395.78 Million CNY | 21.49% |
| 2008 Q2 | 326.11 Million CNY | 1.36% |
| 2007 Q3 | 292.56 Million CNY | -10.11% |
| 2007 Q4 | 325.76 Million CNY | 11.35% |
| 2007 FY | 325.76 Million CNY | 5.99% |
| 2007 Q1 | 347.73 Million CNY | 13.14% |
| 2007 Q2 | 325.46 Million CNY | -6.41% |
| 2006 Q4 | 307.34 Million CNY | -8.39% |
| 2006 Q2 | 344.54 Million CNY | -3.93% |
| 2006 Q1 | 358.62 Million CNY | 2.26% |
| 2006 FY | 307.34 Million CNY | -12.36% |
| 2006 Q3 | 335.5 Million CNY | -2.62% |
| 2005 Q4 | 350.68 Million CNY | -9.14% |
| 2005 Q3 | 385.97 Million CNY | 0.31% |
| 2005 Q2 | 384.8 Million CNY | -6.69% |
| 2005 Q1 | 412.41 Million CNY | 6.08% |
| 2005 FY | 350.68 Million CNY | -9.79% |
| 2004 Q2 | 388.97 Million CNY | 6.85% |
| 2004 FY | 388.76 Million CNY | 10.32% |
| 2004 Q1 | 364.03 Million CNY | 3.31% |
| 2004 Q3 | 370.66 Million CNY | -4.71% |
| 2004 Q4 | 388.76 Million CNY | 4.88% |
| 2003 Q2 | 322.33 Million CNY | 1.4% |
| 2003 Q3 | 325.06 Million CNY | 0.85% |
| 2003 Q1 | 317.87 Million CNY | 1.54% |
| 2003 FY | 352.38 Million CNY | 12.56% |
| 2003 Q4 | 352.38 Million CNY | 8.4% |
| 2002 FY | 313.04 Million CNY | 13.85% |
| 2002 Q2 | 272.93 Million CNY | -63.64% |
| 2002 Q1 | 750.71 Million CNY | 173.02% |
| 2002 Q3 | 305.79 Million CNY | 12.04% |
| 2002 Q4 | 313.04 Million CNY | 2.37% |
| 2001 Q2 | 246.1 Million CNY | 0.0% |
| 2001 Q4 | 274.96 Million CNY | 0.0% |
| 2001 FY | 274.96 Million CNY | 41.24% |
| 2000 Q2 | 154.68 Million CNY | 0.0% |
| 2000 FY | 194.67 Million CNY | -2.41% |
| 2000 Q4 | 194.67 Million CNY | 0.0% |
| 1999 Q4 | 199.48 Million CNY | 0.0% |
| 1999 Q2 | 197.08 Million CNY | 0.0% |
| 1999 FY | 199.48 Million CNY | 6.79% |
| 1998 FY | 186.8 Million CNY | 11.96% |
| 1997 FY | 166.84 Million CNY | 50.69% |
| 1996 FY | 110.71 Million CNY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Zhejiang Int'l Group Co.,Ltd. | 9.12 Billion CNY | 82.065% |
| Zhejiang Zhenyuan Share Co., Ltd. | 974.86 Million CNY | -67.928% |
| Hunan Jingfeng Pharmaceutical Co.,Ltd. | 1.21 Billion CNY | -34.846% |
| Yifan Pharmaceutical Co., Ltd. | 3.14 Billion CNY | 47.946% |
| Guangdong Jiaying Pharmaceutical Co., Ltd | 84.57 Million CNY | -1835.561% |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 13.22 Billion CNY | 87.617% |
| Chongqing Lummy Pharmaceutical Co., Ltd. | 762.32 Million CNY | -114.748% |
| Boai NKY Medical Holdings Ltd. | 499.66 Million CNY | -227.636% |
| Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. | 258.46 Million CNY | -533.392% |